[HTML][HTML] Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review

S Nakahata, D Enriquez-Vera, MI Jahan, K Sugata… - Biomolecules, 2023 - mdpi.com
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL).
HTLV-1 carriers have a lifelong asymptomatic balance between infected cells and host …

Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma

JS O'Donnell, SK Hunt, KJ Chappell - The Lancet Haematology, 2023 - thelancet.com
The human T-lymphotropic virus type 1 (HTLV-1) retrovirus infects 10–20 million people
globally, with endemic regions in southwestern Japan, the Caribbean basin, Africa, and …

HTLV-1 persistence and the oncogenesis of adult T-cell leukemia/lymphoma

CRM Bangham - Blood, The Journal of the American Society of …, 2023 - ashpublications.org
Human T-cell leukemia virus type I (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL)
in 5% of infected people with a decades-long latency. Charles RM Bangham reviews the …

[HTML][HTML] Bibliometric and visual analysis of single-cell sequencing from 2010 to 2022

L Chen, Y Wan, T Yang, Q Zhang, Y Zeng… - Frontiers in …, 2024 - frontiersin.org
Background: Single-cell sequencing (SCS) is a technique used to analyze the genome,
transcriptome, epigenome, and other genetic data at the level of a single cell. The procedure …

Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma

J Yasunaga - International Journal of Hematology, 2023 - Springer
Adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature CD4+ T cells induced by
human T-cell leukemia virus type I (HTLV-1). HTLV-1 maintains life-long infection in the …

HTLV‐1 persistent infection and ATLL oncogenesis

X Zuo, R Zhou, S Yang, G Ma - Journal of Medical Virology, 2023 - Wiley Online Library
Human T‐cell leukemia virus type 1 (HTLV‐1) was discovered in the 1980s, but it is
estimated to have been infecting humans for more than ten thousand years. 1 With over 90 …

[HTML][HTML] HTLV-1 persistence and leukemogenesis: a game of hide-and-seek with the host immune system

BJY Tan, K Sugata, M Ono, Y Satou - Frontiers in Immunology, 2022 - frontiersin.org
Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus which mainly infects CD4+ T cells
and causes adult T-cell leukemia/lymphoma (ATL), is primarily transmitted via direct cell-to …

[HTML][HTML] Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers

T Kameda, A Utsunomiya, N Otsuka, Y Kubuki… - BMC Infectious …, 2024 - Springer
Background Whether human T-lymphotropic virus type 1 (HTLV-1) carriers can develop
sufficient humoral immunity after coronavirus disease 2019 (COVID-19) vaccination is …

[HTML][HTML] Development of a monoclonal antibody targeting HTLV-1 envelope gp46 glycoprotein and its application to near-infrared photoimmuno-antimicrobial strategy

Y Hatayama, Y Yamaoka, T Morita, SS Jeremiah… - Viruses, 2022 - mdpi.com
Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus, causes adult T-cell leukemia-
lymphoma, HTLV-1 associated myelopathy/tropical spastic paraparesis, and HTLV-1 uveitis …

Immune landscape of viral cancers: insights from single‐cell sequencing

T Lei, X Li, F Wang, Q Huang, T Liu… - Journal of Medical …, 2023 - Wiley Online Library
Viral infections trigger a wide range of immune responses thought to drive tumorigenesis
and malignant progression. Dissecting virus‐induced changes in the tumor immune …